\(
\def\WIPO{World Intellectual Property Organisation}
\)
Intellectual Property Rights and the Financing of Technological Innovation : Public Policy and the Efficiency of Capital Markets.
2013
F 630 FRE.I
Available at WIPO Library
格式
| 格式 | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
详细记录
Title
Intellectual Property Rights and the Financing of Technological Innovation : Public Policy and the Efficiency of Capital Markets.
Author
描述
304 pages : illustrations ; 24 cm.
国际图书编号
9781782545897 Print
9781782545903 eBook
9781782545903 eBook
Alternate Call Number
F 630 FRE.I
摘要
Following the transition of industrial nations to knowledge economies, the financing of technological innovation has become a central issue in public policy, corporate finance and business management. This detailed book examines the role of intellectual property rights in facilitating the financing of technological innovation as well as the role of policy makers, investors and managers in this process. The book’s central finding is that public policy plays a key role in promoting the corporate disclosure of intellectual property-related information to enhance the efficiency of capital markets. This not only reduces the costs of capital for technology-driven firms but ultimately spurs innovation and economic growth. Intellectual Property Rights and the Financing of Technological Innovation will strongly appeal to research students and academics, policy makers, intellectual property professionals, equity analysts, credit rating analysts and executives in the pharmaceutical industry.
书目等附注
Includes bibliographical references (pages 250-279) and index.
格式化内容附注
1. Introduction;
2. The intangible economy;
3. Patent information and corporate credit ratings: an empirical study of patent valuation by credit rating agencies;
4. IPR management and company valuation in the pharmaceutical industry: an exploratory study;
5. IPR management, corporate disclosures, and stock market valuations in the pharmaceutical industry;
6. Towards forward-looking financial reporting;
Bibliography;
Index
2. The intangible economy;
3. Patent information and corporate credit ratings: an empirical study of patent valuation by credit rating agencies;
4. IPR management and company valuation in the pharmaceutical industry: an exploratory study;
5. IPR management, corporate disclosures, and stock market valuations in the pharmaceutical industry;
6. Towards forward-looking financial reporting;
Bibliography;
Index
Published
Cheltenham, UK : Edward Elgar, 2013.
语言
eng
记录出处